|
CSRNP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.77910000000092E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.029520E-04 |
| Normal-vs-Stage2 |
4.13580000002689E-06 |
| Normal-vs-Stage3 |
1.58432999999292E-05 |
| Normal-vs-Stage4 |
2.47180000001457E-06 |
| Stage1-vs-Stage2 |
6.326500E-02 |
| Stage1-vs-Stage3 |
1.063790E-01 |
| Stage1-vs-Stage4 |
3.502500E-02 |
| Stage2-vs-Stage3 |
7.687800E-01 |
| Stage2-vs-Stage4 |
6.448000E-01 |
| Stage3-vs-Stage4 |
4.959600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.35499999999833E-05 |
| Normal-vs-AfricanAmerican |
2.043400E-04 |
| Normal-vs-Asian |
1.06710000002952E-06 |
| Caucasian-vs-AfricanAmerican |
3.002200E-01 |
| Caucasian-vs-Asian |
3.213700E-02 |
| AfricanAmerican-vs-Asian |
1.961530E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69120000000001E-05 |
| Normal-vs-Female |
8.12460000000348E-05 |
| Male-vs-Female |
8.111800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.69859999999256E-05 |
| Normal-vs-Extreme_Weight |
5.83020000000101E-05 |
| Normal-vs-Obese |
5.71889999999575E-05 |
| Normal-vs-Extreme_Obese |
9.79239999999715E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.572800E-01 |
| Normal_Weight-vs-Obese |
8.219200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.425800E-01 |
| Extreme_Weight-vs-Obese |
9.334400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.843600E-01 |
| Obese-vs-Extreme_Obese |
8.177800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.866180E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64932999999756E-05 |
| Normal-vs-Age(61-80Yrs) |
6.04330000000264E-05 |
| Normal-vs-Age(81-100Yrs) |
1.432300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.546000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.220000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.498600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.586600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.329600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.715800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.0245999999966E-05 |
| Normal-VS-Type2 PRCC |
3.85880000000061E-05 |
| Normal-VS-KIRP CIMP |
5.679100E-03 |
| Normal-VS-Unclassified PRCC |
1.24619999997133E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.128400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.371800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.064300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.527600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.424100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.248100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76279999997142E-06 |
| Normal-vs-N1 |
2.76720000003117E-06 |
| Normal-vs-N2 |
8.035600E-02 |
| N0-vs-N1 |
8.755400E-01 |
| N0-vs-N2 |
5.290000E-01 |
| N1-vs-N2 |
6.673200E-01 |
|
|
